Alan Sabirsh

机构：Advanced Pharma, AstraZeneca (Brazil), AstraZeneca (Italy) · ORCID：0000-0001-5310-0281

发表论文 64 篇 · 总被引 3823 次 · h-index 26

代表论文

• Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale (2021 · The Journal of Cell Biology · 被引 202)
• Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function (2023 · Nature Communications · 被引 111)
• Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion (2022 · ACS Nano · 被引 77)
• TECPR1 is activated by damage‐induced sphingomyelin exposure to mediate noncanonical autophagy (2023 · The EMBO Journal · 被引 75)
• Precise and systematic end group chemistry modifications on PAMAM and poly(l-lysine) dendrimers to improve cytosolic delivery of mRNA (2023 · Journal of Controlled Release · 被引 56)
• Deep-Learning Models for Lipid Nanoparticle-Based Drug Delivery (2021 · Nanomedicine · 被引 53)